Rocket Lab's Neutron debut slipped to 2027 after propellant-dome manufacturing defects, driving a 6.6% drop. KeyBanc's target cut to $100 from $135, trimming 2027 revenue by roughly $53 million for one lost launch, signals multiple compression across high-growth space names. Near-term sentiment stays pressured, though the reiterated Buy and intact Space Systems outlook limit broader sector contagion.
AI Insight · NCSKRKLB2USD/USDTAI Insight
▼ Bearish
⚠️ AI-generated insights are based on news content and are provided for informational purposes only. They do not constitute investment advice or represent the views of BingX. Investing involves risk. Please trade responsibly.
Rocket Lab (RKLB) stock fell 6.6% on Thursday after the space company delayed the launch of its much-awaited Neutron rocket to 2027. Following t...